OXYGEN
16/03/2006, 08h07
Schering-Plough's big bet against Pfizer
Drugmaker's stock could be set for a rebound, based on the up-and-coming cholesterol drug Vytorin.
By Aaron Smith, CNNMoney.com staff writer
March 15, 2006: 4:22 PM EST
NEW YORK (CNNMoney.com) - Schering-Plough, once the troubled child of the drug industry, is making a comeback with a hot new drug.
The drugmaker, based in Kenilworth, N. J., has armed itself with a fast-growing cholesterol treatment, Vytorin, and appears to have left its woes in the dust.
http://money.cnn.com/2006/03/15/news/companies/vytorin/
NDLR : Pfizer a du souci à se faire pour son Lipitor , coincé entre le Vytorin et le Crestor !
Drugmaker's stock could be set for a rebound, based on the up-and-coming cholesterol drug Vytorin.
By Aaron Smith, CNNMoney.com staff writer
March 15, 2006: 4:22 PM EST
NEW YORK (CNNMoney.com) - Schering-Plough, once the troubled child of the drug industry, is making a comeback with a hot new drug.
The drugmaker, based in Kenilworth, N. J., has armed itself with a fast-growing cholesterol treatment, Vytorin, and appears to have left its woes in the dust.
http://money.cnn.com/2006/03/15/news/companies/vytorin/
NDLR : Pfizer a du souci à se faire pour son Lipitor , coincé entre le Vytorin et le Crestor !